Advanced Malignant Solid Neoplasm Clinical Trials in New Haven, Connecticut

4 studies are recruiting for advanced malignant solid neoplasm in New Haven, Connecticut right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Personalized Antibody-Drug Conjugate Therapy Based on RNA and Protein Testing for the Treatment of Advanced or Metastatic Solid Tumors (The ADC MATCH Screening and Treatment Trial)

    This phase II ADC MATCH screening and multi-sub-study treatment trial is evaluating whether biomarker-directed treatment with one of three antibody-drug conjugates (ADCs) (sacituzumab govitecan, enfortumab vedotin, and trastuzumab deruxtecan) works in treating patients with solid tumor cancers that…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    27 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT06311214 on ClinicalTrials.gov

  2. Testing the Combination of the Anti-cancer Drugs ZEN003694 (ZEN-3694) and Talazoparib in Patients With Advanced Solid Tumors, The ComBET Trial

    This phase II trial tests whether ZEN003694 (ZEN-3694) in combination with talazoparib works to shrink tumors in patients with solid tumors that are unlikely to be cured or controlled with treatment and that may have spread from where it first started to nearby tissue, lymph nodes, or distant parts…

    Stage
    Phase 2
    Ages
    18 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    36 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05327010 on ClinicalTrials.gov

  3. Testing the Combination of the Anti-Cancer Drugs Temozolomide and M1774 to Evaluate Their Safety and Effectiveness

    This phase I/II trial studies the side effects and best dose of temozolomide and M1774 and how well they works in treating patients with cancer that has spread from where it first started (primary site) to other places in the body (metastatic) and may have spread to nearby tissue, lymph nodes, or d…

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    23 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05691491 on ClinicalTrials.gov

  4. Testing A New Anti-cancer Drug Combination, Entinostat and ZEN003694, for Advanced and Refractory Solid Tumors

    This phase I/II trial tests the safety, side effects, and best dose of entinostat and ZEN003694 in treating patients with solid tumors that have spread to other places in the body (advanced) or does not respond to treatment (refractory). Entinostat is in a class of drugs called histone deacetylase …

    Stage
    Phase 1
    Ages
    18 and older
    Site
    Yale University, New Haven, Connecticut
    Locations
    3 in total
    Run by
    National Cancer Institute (NCI)

    See if you can join NCT05053971 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.